BRAF and melanoma: In conclusion, we unveil that the distinct regulatory patterns of laminB1 on apoptosis and autophagy cooperatively contribute to the BRAFi resistance in BRAF-mutated melanoma cells, implying the potential of laminB1 in promoting efficacy of targeted therapies.